Valuation: Fusen Pharmaceutical Company Limited

Market Cap 545M 640M 81.53M 72.68M 67.33M 61.21M 115M 7.73B 117M 808M 318M 4.04B 306M 300M 12.92B P/E 2024
-2.95x
P/E 2025 -45.1x
Enterprise Value 767M 900M 115M 102M 94.74M 86.14M 162M 10.88B 164M 1.14B 447M 5.69B 430M 421M 18.17B EV / Sales 2024
2.83x
EV / Sales 2025 2.76x
Free-Float
26.11%
Yield 2024 *
-
Yield 2025 -
1 week-8.95%
Current month-3.89%
1 month+4.22%
3 months-16.02%
6 months-29.10%
Current year+8.12%
1 week 0.81
Extreme 0.81
0.93
1 month 0.72
Extreme 0.72
1.05
Current year 0.67
Extreme 0.67
1.44
1 year 0.64
Extreme 0.64
1.44
3 years 0.24
Extreme 0.235
1.75
5 years 0.24
Extreme 0.235
2.74
10 years 0.24
Extreme 0.235
20
Manager TitleAgeSince
Director of Finance/CFO 48 17/04/2019
Investor Relations Contact 40 17/01/2013
Corporate Secretary 36 29/09/2024
Director TitleAgeSince
Director/Board Member 63 06/04/2017
Director/Board Member 64 06/04/2017
Director/Board Member 61 06/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
19/04/24 Other

Chairman

650,000 0.0867%
18/04/24 Other

Chairman

240,000 0.0320%
18/04/24 Other

Chairman

240,000 0.0320%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-8.95%+18.49%-42.33% 81.49M
-1.33%+4.88%+54.50%+109.94% 1,120B
-0.69%-3.77%+31.35%+66.62% 616B
-0.96%+0.55%+23.13%+94.26% 504B
+0.24%+5.58%+33.98%+59.40% 367B
-1.59%-1.25%+69.39%+43.02% 360B
-0.40%+3.53%+19.17%+46.55% 288B
-0.37%+3.11%-1.26%+18.23% 258B
-1.75%+1.76%+42.21%+51.44% 234B
-2.00%+1.75%+24.64%+95.14% 194B
Average -0.89%+0.59%+31.56%+54.23% 394.1B
Weighted average by Cap. -0.99%+2.42%+37.89%+75.52%

Financials

2024 2025
Net sales 326M 383M 48.75M 43.46M 40.26M 36.6M 68.68M 4.62B 69.81M 483M 190M 2.42B 183M 179M 7.72B 273M 321M 40.88M 36.44M 33.75M 30.69M 57.59M 3.88B 58.54M 405M 159M 2.03B 153M 150M 6.48B
Net income -189M -222M -28.23M -25.16M -23.31M -21.19M -39.77M -2.68B -40.42M -280M -110M -1.4B -106M -104M -4.47B -11.78M -13.83M -1.76M -1.57M -1.46M -1.32M -2.48M -167M -2.52M -17.45M -6.86M -87.32M -6.61M -6.47M -279M
Net Debt 367M 431M 54.92M 48.95M 45.35M 41.23M 77.37M 5.21B 78.64M 544M 214M 2.72B 206M 202M 8.7B 222M 261M 33.2M 29.59M 27.41M 24.92M 46.77M 3.15B 47.54M 329M 129M 1.64B 125M 122M 5.26B
Projected Income Statement - Annual - Fusen Pharmaceutical Company Limited
Logo Fusen Pharmaceutical Company Limited
Fusen Pharmaceutical Co Ltd is a company mainly engaged in the cultivation of Chinese herbal medicine, pharmaceutical research and development, and sales. The Company's main business is the sales of Shuanghuanglian Oral Solutions, Shuanghuanglian Injections and other pharmaceutical products. The Company is also engaged in the research, production, and sales of various proprietary Chinese medicine and western medicine products for treating cold, fever, cardiovascular diseases and anemia. The Company mainly conducts business in the domestic market.
Employees
817
Date Price Change Volume
16/10/26 HK$0.8650 0.00% 0
15/10/26 HK$0.8650 -6.99% 23,000
14/10/26 HK$0.9300 0.00% 1,000
13/10/26 HK$0.9300 -2.11% 31,000
  1. Stock Market
  2. Stocks
  3. 1652 Stock